MUHAMMAD ISLAM: Open Payments
NPI 1992907133 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$205 in 8 payments from 4 companies in 2025. Trend: 2023 $482 · 2024 $385 · 2025 $205
Food & beverage: $205
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 3 | $77 |
| Neurocrine BioSciences, Inc. | 3 | $74 |
| Alkermes, Inc. | 1 | $27 |
| Janssen Pharmaceuticals, Inc | 1 | $26 |
Products named: INGREZZA, ABILIFY ASIMTUFII, VIVITROL, INVEGA SUSTENNA, ABILIFY MAINTENA.
Industry payments across NY — which companies pay providers there.
